Terms: = Colorectal cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Prognosis
232 results:
1. From Subtypes to Solutions: Integrating CMS Classification with Precision Therapeutics in colorectal cancer.
Ding X; Huang H; Fang Z; Jiang J
Curr Treat Options Oncol; 2024 Dec; 25(12):1580-1593. PubMed ID: 39589648
[TBL] [Abstract] [Full Text] [Related]
2. TRIM21 induces selective autophagic degradation of c-myc and sensitizes regorafenib therapy in colorectal cancer.
Ye WL; Huang L; Yang XQ; Wan S; Gan WJ; Yang Y; He XS; Liu F; Guo X; Liu YX; Hu G; Li XM; Shi WY; He K; Wu YY; Wu WX; Lu JH; Song Y; Qu CJ; Wu H
Proc Natl Acad Sci U S A; 2024 Oct; 121(42):e2406936121. PubMed ID: 39388269
[TBL] [Abstract] [Full Text] [Related]
3. TRIM40 interacts with ROCK1 directly and inhibits colorectal cancer cell proliferation through the c-myc/p21 axis.
Hu F; Zhao L; Wang J; Li X; Xue Z; Ma Y; Zheng M; Chen C; Tong M; Guo X; Li H; Jin H; Xie Q; Zhang X; Huang C; Huang H
Biochim Biophys Acta Mol Cell Res; 2024 Dec; 1871(8):119855. PubMed ID: 39357549
[TBL] [Abstract] [Full Text] [Related]
4. Impact of CDKN2A gene expression on colon adenocarcinoma via biosignature analysis.
Xu C
Medicine (Baltimore); 2024 Sep; 103(36):e39408. PubMed ID: 39252310
[TBL] [Abstract] [Full Text] [Related]
5. LINC00460/miR-186-3p/myc feedback loop facilitates colorectal cancer immune escape by enhancing CD47 and PD-L1 expressions.
Luo Q; Shen F; Zhao S; Dong L; Wei J; Hu H; Huang Q; Wang Q; Yang P; Liang W; Li W; He F; Cao J
J Exp Clin Cancer Res; 2024 Aug; 43(1):225. PubMed ID: 39135122
[TBL] [Abstract] [Full Text] [Related]
6. Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-myc translation.
Jiang X; Peng M; Liu Q; Peng Q; Oyang L; Li S; Xu X; Shen M; Wang J; Li H; Wu N; Tan S; Lin J; Xia L; Tang Y; Luo X; Liao Q; Zhou Y
Mol Cancer; 2024 Jul; 23(1):151. PubMed ID: 39085875
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
[No Abstract] [Full Text] [Related]
8. Forkhead box M1 mediates metabolic reprogramming in human colorectal cancer cells.
Li PC; Dai SY; Lin YS; Chang YT; Liu CC; Wang IC; Lee MF
Am J Physiol Gastrointest Liver Physiol; 2024 Aug; 327(2):G284-G294. PubMed ID: 38953837
[TBL] [Abstract] [Full Text] [Related]
9. CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphoma.
Wang Y; Chen J; Gao Y; Chai KXY; Hong JH; Wang P; Chen J; Yu Z; Liu L; Huang C; Taib NAM; Lim KMH; Guan P; Chan JY; Huang D; Teh BT; Li W; Lim ST; Yu Q; Ong CK; Huang H; Tan J
Cancer Lett; 2024 Aug; 597():217080. PubMed ID: 38908542
[TBL] [Abstract] [Full Text] [Related]
10. MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration.
Chen J; Duan S; Wang Y; Ling Y; Hou X; Zhang S; Liu X; Long X; Lan J; Zhou M; Xu H; Zheng H; Zhou J
Nat Commun; 2024 Jun; 15(1):4969. PubMed ID: 38862489
[TBL] [Abstract] [Full Text] [Related]
11. The mechanism of RGS5 regulating gastric cancer mismatch repair protein.
Yang Z; Zhang R; Liu J; Tian S; Zhang H; Zeng L; Zhang Y; Gao L; Wang M; Shan W; Liu J
Mol Carcinog; 2024 Sep; 63(9):1750-1767. PubMed ID: 38860604
[TBL] [Abstract] [Full Text] [Related]
12. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
[TBL] [Abstract] [Full Text] [Related]
13. myc and NCAPG2 as molecular targets of colorectal cancer and gastric cancer in nursing.
Mi X; Shan H; Kang C; Zhang J; Hou S; Gao Y; Hao L; Gao X; Gao Q; Chi X; Zhang Q
Medicine (Baltimore); 2024 May; 103(18):e38029. PubMed ID: 38701261
[TBL] [Abstract] [Full Text] [Related]
14. Identification of genes related to ribosomal proteins in colorectal cancer: exploring their potential as biomarkers, prognostic indicators, and therapeutic targets.
Salehinia N; Mohammad Al-Mosawi AK; Al-Moussawi DK; Sadeghi ES; Zamani A; Mahdevar M
Mol Biol Rep; 2024 Apr; 51(1):576. PubMed ID: 38664314
[TBL] [Abstract] [Full Text] [Related]
15. Mining and exploration of rehabilitation nursing targets for colorectal cancer.
Li R; He J; Ni Z; Zhang J; Chi X; Kang C; Li Z; Li X
Aging (Albany NY); 2024 Apr; 16(8):7022-7042. PubMed ID: 38637125
[TBL] [Abstract] [Full Text] [Related]
16. Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways.
D'Antona S; Porro D; Gallivanone F; Bertoli G
Comput Biol Med; 2024 May; 174():108346. PubMed ID: 38581999
[TBL] [Abstract] [Full Text] [Related]
17. Identification of unique rectal cancer-specific subtypes.
Kisakol B; Matveeva A; Salvucci M; Kel A; McDonough E; Ginty F; Longley DB; Prehn JHM
Br J Cancer; 2024 May; 130(11):1809-1818. PubMed ID: 38532103
[TBL] [Abstract] [Full Text] [Related]
18. miR-575/RIPK4 axis modulates cell cycle progression and proliferation by inactivating the Wnt/β-catenin signaling pathway through inhibiting RUNX1 in colon cancer.
Wang Q; Lu W; Lu L; Wu R; Wu D
Mol Cell Biochem; 2024 Jul; 479(7):1747-1766. PubMed ID: 38480605
[TBL] [Abstract] [Full Text] [Related]
19. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
[TBL] [Abstract] [Full Text] [Related]
20. Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer.
Mollanoori H; Ghelmani Y; Hassani B; Dehghani M
Sci Rep; 2024 Jan; 14(1):91. PubMed ID: 38167453
[TBL] [Abstract] [Full Text] [Related]
[Next]
